102 Participants Needed

RCBI Program for TBI Recidivism Reduction

(RCBI Trial)

CC
Overseen ByCori Conner, MA
Age: 18+
Sex: Male
Trial Phase: Academic
Sponsor: Rehabilitation Hospital of Indiana
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial aims to help people with brain injuries who are being released from prison by providing a special program that supports their unique needs. The goal is to reduce their chances of going back to prison and committing violent crimes by offering tailored services that help them manage their behavior and integrate into the community.

Research Team

DP

Devan Parrott, PhD

Principal Investigator

Indiana University

Eligibility Criteria

This trial is for adults with a history of moderate to severe traumatic brain injury (TBI) who are currently serving sentences at PCF in Greencastle, Indiana and have 5 to 8 months left in their sentence. It's not for those in solitary confinement or unable to understand the study.

Inclusion Criteria

I am 18 years old or older.
Offenders currently serving their sentence at PCF in Greencastle, Indiana
History of moderate to severe TBI
See 1 more

Exclusion Criteria

I need someone legally authorized to make decisions for me.
I understand the details of the study.
In restricted housing (e.g., solitary confinement)

Timeline

Screening

Participants are screened for eligibility to participate in the trial

8 months

Intervention

Participants receive the Reentry Continuum for Brain Injury (RCBI) intervention or treatment as usual (TAU-CG) prior to release

3 months

Follow-up

Participants are monitored for recidivism, violent offenses, coping, aggression, community integration, and employment post-release

3 years

Treatment Details

Interventions

  • Reentry Continuum for Brain Injury (RCBI)
Trial OverviewThe trial tests if the Reentry Continuum for Brain Injury (RCBI) program can reduce re-incarceration and violent offenses among TBI patients post-release. Participants will be randomly assigned to RCBI or typical aftercare and tracked for three years.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: RCBIExperimental Treatment1 Intervention
Receiving RCBI intervention, including BICS, ICAN, and RF.
Group II: Treatment as usual- Control groupActive Control1 Intervention
Not receiving the RCBI intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Rehabilitation Hospital of Indiana

Lead Sponsor

Trials
13
Recruited
5,500+